SCHEMBL20152217

SCHEMBL20152217

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4c5c6ccccc6n(-c6cnc7c8ccccc8c8ccccc8c7n6)c5ccc43)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.34
MAPK1 P28482 3/20 0.34
NPSR1 Q6W5P4 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
NPC1 O15118 2/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 2/20 0.32
TSHR P16473 2/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
ALOX12 P18054 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
RAB9A P51151 1/20 0.32
CYP19A1 P11511 1/20 0.31
HPGD P15428 2/20 0.31
ADORA2A P29274 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20152180 0.88 TLR7 (0.32) MAPTNPC1LMNASMN1; SMN2RAB9A
SCHEMBL19655108 0.85 GABRP (0.38) MAPTMAPK1L3MBTL1KDM4EMEN1
SCHEMBL12175712 0.84 MEN1 (0.42) MAPTMAPK1NPSR1L3MBTL1KDM4E
SCHEMBL20152172 0.84 MAPT (0.35) MAPTMAPK1NPSR1L3MBTL1KDM4E
SCHEMBL19653788 0.83 KDM4E (0.33) L3MBTL1KDM4E
SCHEMBL19653812 0.82 L3MBTL1 (0.37) MAPTL3MBTL1KDM4EMEN1KMT2A
SCHEMBL18124871 0.82 L3MBTL1 (0.37) MAPTL3MBTL1KDM4EMEN1KMT2A
SCHEMBL19653789 0.82 KDM4E (0.35) L3MBTL1KDM4EMEN1KMT2AALDH1A1
SCHEMBL19653787 0.82 KDM4E (0.45) MAPTMAPK1L3MBTL1KDM4EMEN1
SCHEMBL20226307 0.81 MAPT (0.38) MAPTMAPK1NPSR1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662196-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-05-26 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662196-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, SLCO4C1 MAPT 689/4885MAPK1 2618/4885NPSR1 3702/4885
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, SLCO4C1 MAPT 689/4885MAPK1 2618/4885NPSR1 3702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.